Literature DB >> 8613957

Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.

F Brunner1, K Schmidt, E B Nielsen, B Mayer.   

Abstract

The aim of the present study was: 1) to determine the effects of the novel selective inhibitor of guanylyl cyclase, ODQ (1H-[1,2,4]oxadiazolo[4,3,-a]quinoxaline-1-one) on basal and agonist-stimulated cyclic GMP levels in cultured porcine aortic endothelial cells and bovine pulmonary artery strips; 2) to determine its effects on agonist-induced relaxations of bovine pulmonary artery strips; and 3) to compare pulmonary artery cyclic GMP levels with vessel relaxation. ODQ (1 nM-30 microM) inhibited cyclic GMP accumulation in endothelial cells stimulated with S-nitrosoglutathione, nitroprusside and 3-morpholine-sydnonimine at IC50 values of 40 to 100 nM. Complete suppression of cyclic GMP generation was observed at approximately 10 microM. Relaxation of pulmonary artery strips induced by S-nitrosoglutathione, nitroprusside, glycerol trinitrate, nitrite (all endothelium-independent), bradykinin and the Ca++ ionophore A23187 (endothelium-dependent) were antagonized by ODQ (1-10 microM) in a concentration-dependent way. A consistent feature of the inhibitor was that maximal relaxant effects also were reduced. Basal levels and agonist-induced increases in arterial tissue cyclic GMP were inhibited in the same concentration range. However, tissue cyclic GMP production correlated poorly with pulmonary artery relaxation in that relaxations induced by S-nitrosoglutathione were only inhibited in part (50%), whereas rises in cyclic GMP were abolished completely by ODQ (10 microM). Furthermore, at 1 microM, ODQ had no effect on relaxation induced by endothelium-dependent agonists, but prevented entirely stimulation of cyclic GMP accumulation in arterial tissue. These results suggest that ODQ inhibits nitrovasodilator-induced and endothelium-dependent relaxation through inhibition of guanylyl cyclase activation, but also point to the presence of a cyclic GMP-independent component of relaxation in bovine pulmonary artery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613957

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Isoforms of NO-sensitive guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Nitric oxide in plant immunity.

Authors:  A Hausladen; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1.

Authors:  S Pervin; R Singh; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Inhibition of endotoxin-induced vascular hyporeactivity by 4-amino-tetrahydrobiopterin.

Authors:  H D Gibraeil; P Dittrich; S Saleh; B Mayer
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

6.  Rebound stimulation of the cAMP-regulated Cl- current by acetylcholine in guinea-pig ventricular myocytes.

Authors:  S I Zakharov; R D Harvey
Journal:  J Physiol       Date:  1997-02-15       Impact factor: 5.182

7.  Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.

Authors:  J W Wegener; E I Closs; U Förstermann; H Nawrath
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Identification of the enzymatic mechanism of nitroglycerin bioactivation.

Authors:  Zhiqiang Chen; Jian Zhang; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

9.  Phenylephrine acts via IP3-dependent intracellular NO release to stimulate L-type Ca2+ current in cat atrial myocytes.

Authors:  Y G Wang; E N Dedkova; X Ji; L A Blatter; S L Lipsius
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

10.  Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes.

Authors:  Elena N Dedkova; Yong Gao Wang; Lothar A Blatter; Stephen L Lipsius
Journal:  J Physiol       Date:  2002-08-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.